Dermata Therapeutics, Inc. (DRMA)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Sep 04, 16:00
1.24
+0.03
(+2.48%)
After-Hours: 20:00
Dermata Therapeutics Price to Book Value : 1.395 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 1.395 |
| September 03, 2026 | 1.418 |
| September 02, 2026 | 1.476 |
| September 01, 2026 | 1.499 |
| August 31, 2026 | 1.488 |
| August 28, 2026 | 1.545 |
| August 27, 2026 | 1.684 |
| August 26, 2026 | 1.857 |
| August 25, 2026 | 1.984 |
| August 24, 2026 | 1.880 |
| August 21, 2026 | 1.638 |
| August 20, 2026 | 1.591 |
| August 19, 2026 | 1.695 |
| August 18, 2026 | 1.649 |
| August 17, 2026 | 1.684 |
| August 14, 2026 | 1.684 |
| August 13, 2026 | 1.811 |
| August 12, 2026 | 1.591 |
| August 11, 2026 | 1.246 |
| August 10, 2026 | 1.292 |
| August 07, 2026 | 1.268 |
| August 06, 2026 | 1.280 |
| August 05, 2026 | 1.349 |
| August 04, 2026 | 1.268 |
| August 03, 2026 | 1.240 |
| Date | Value |
|---|---|
| July 31, 2026 | 1.349 |
| July 30, 2026 | 1.361 |
| July 29, 2026 | 1.361 |
| July 28, 2026 | 1.424 |
| July 27, 2026 | 1.488 |
| July 24, 2026 | 1.522 |
| July 23, 2026 | 1.453 |
| July 22, 2026 | 1.453 |
| July 21, 2026 | 1.476 |
| July 20, 2026 | 1.465 |
| July 17, 2026 | 1.534 |
| July 16, 2026 | 1.476 |
| July 15, 2026 | 1.499 |
| July 14, 2026 | 1.522 |
| July 13, 2026 | 1.557 |
| July 10, 2026 | 1.545 |
| July 09, 2026 | 1.545 |
| July 08, 2026 | 1.614 |
| July 07, 2026 | 1.626 |
| July 06, 2026 | 1.545 |
| July 02, 2026 | 1.545 |
| July 01, 2026 | 1.591 |
| June 30, 2026 | 1.488 |
| June 29, 2026 | 0.8153 |
| June 26, 2026 | 0.8091 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.029 |
| Perspective Therapeutics, Inc. | 1.103 |
| MiMedx Group, Inc. | 3.083 |
| ABVC BioPharma, Inc. | 2.405 |
| Endonovo Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| Price | 1.21 |
| Earnings Yield | -362.5% |
| Market Cap | 4.867M |